Mark Stevenson

1.9k total citations
50 papers, 1.2k citations indexed

About

Mark Stevenson is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Mark Stevenson has authored 50 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 18 papers in Genetics and 15 papers in Epidemiology. Recurrent topics in Mark Stevenson's work include Virus-based gene therapy research (12 papers), Neuroendocrine Tumor Research Advances (12 papers) and RNA Interference and Gene Delivery (10 papers). Mark Stevenson is often cited by papers focused on Virus-based gene therapy research (12 papers), Neuroendocrine Tumor Research Advances (12 papers) and RNA Interference and Gene Delivery (10 papers). Mark Stevenson collaborates with scholars based in United Kingdom, United States and Czechia. Mark Stevenson's co-authors include Rajesh V. Thakker, Leonard W. Seymour, Kerry D. Fisher, Simon S. Briggs, Kate E Lines, Luís Cardoso, Martin L. Read, Jon A. Preece, Surjeet Singh and Nandini V. Katre and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Mark Stevenson

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Stevenson United Kingdom 17 680 421 300 206 161 50 1.2k
Yating Tu China 21 589 0.9× 60 0.1× 249 0.8× 174 0.8× 22 0.1× 87 1.3k
Gianluca Carlesso United States 19 211 0.3× 74 0.2× 215 0.7× 77 0.4× 28 0.2× 28 1.2k
Stephen H. Wrzesinski United States 13 705 1.0× 130 0.3× 872 2.9× 81 0.4× 8 0.0× 20 2.1k
Wentao Deng United States 16 947 1.4× 113 0.3× 206 0.7× 119 0.6× 13 0.1× 40 1.3k
Sachiko Hirosue Switzerland 16 787 1.2× 137 0.3× 560 1.9× 100 0.5× 10 0.1× 21 1.7k
Joseph D. Ferrari United States 11 357 0.5× 77 0.2× 91 0.3× 94 0.5× 18 0.1× 14 1.0k
Jeremy B. Foote United States 18 242 0.4× 253 0.6× 255 0.8× 65 0.3× 11 0.1× 66 1.1k
Sheng Hou China 26 798 1.2× 123 0.3× 533 1.8× 109 0.5× 5 0.0× 73 1.8k
Christian H.K. Lehmann Germany 23 484 0.7× 90 0.2× 343 1.1× 91 0.4× 9 0.1× 52 1.5k

Countries citing papers authored by Mark Stevenson

Since Specialization
Citations

This map shows the geographic impact of Mark Stevenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stevenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stevenson more than expected).

Fields of papers citing papers by Mark Stevenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Stevenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stevenson. The network helps show where Mark Stevenson may publish in the future.

Co-authorship network of co-authors of Mark Stevenson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Stevenson. A scholar is included among the top collaborators of Mark Stevenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Stevenson. Mark Stevenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hannan, Fadil, Kreepa Kooblall, Mark Stevenson, et al.. (2025). Characterization of quinazolinone calcilytic therapy for autosomal dominant hypocalcemia type 1 (ADH1). Journal of Biological Chemistry. 301(4). 108404–108404.
2.
Kooblall, Kreepa, Mark Stevenson, Raphael Heilig, et al.. (2024). Identification of cellular retinoic acid binding protein 2 (CRABP2) as downstream target of nuclear factor I/X (NFIX): implications for skeletal dysplasia syndromes. JBMR Plus. 8(7). ziae060–ziae060. 1 indexed citations
3.
Zecchin, Davide, Nicole Knöpfel, Mark Stevenson, et al.. (2023). GNAQ/GNA11 Mosaicism Causes Aberrant Calcium Signaling Susceptible to Targeted Therapeutics. Journal of Investigative Dermatology. 144(4). 811–819.e4. 7 indexed citations
4.
Stevenson, Mark, Kate E Lines, & Rajesh V. Thakker. (2018). Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors. Endocrinology and Metabolism Clinics of North America. 47(3). 525–548. 14 indexed citations
5.
Lines, Kate E, Mark Stevenson, P. Filippakopoulos, et al.. (2017). Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors. Oncogenesis. 6(5). e332–e332. 39 indexed citations
6.
Walls, Gerard, Mark Stevenson, Kate E Lines, et al.. (2017). Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome. Oncogene. 36(28). 4025–4036. 28 indexed citations
7.
Brown, David H., et al.. (2016). ES adoption in Chinese SMEs:institutional effects on users and providers. Journal of the Association for Information Systems. 47. 1 indexed citations
8.
Lines, Kate E, Mark Stevenson, & Rajesh V. Thakker. (2015). Animal models of pituitary neoplasia. Molecular and Cellular Endocrinology. 421. 68–81. 16 indexed citations
9.
10.
Stevenson, Mark, Robert Carlisle, Benjamin Davies, et al.. (2013). Development of a Positive-readout Mouse Model of siRNA Pharmacodynamics. Molecular Therapy — Nucleic Acids. 2. e133–e133. 8 indexed citations
11.
Stevenson, Mark, et al.. (2011). E-selectin is a viable route of infection for polymer-coated adenovirus retargeting in TNF-α-activated human umbilical vein endothelial cells. Journal of drug targeting. 19(8). 690–700. 10 indexed citations
12.
Seymour, Leonard W., et al.. (2009). Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma. Cancer Gene Therapy. 16(10). 764–775. 16 indexed citations
13.
El‐Sherbiny, Yasser M., Mark Stevenson, Leonard W. Seymour, & Richard Wade‐Martins. (2009). Quantitative characterization of cell transduction by HSV-1 amplicons using flow cytometry and real-time PCR. Journal of Virological Methods. 159(2). 160–166. 2 indexed citations
14.
Stevenson, Mark, et al.. (2008). Cancer gene therapy with targeted adenoviruses. Expert Opinion on Drug Delivery. 5(11). 1231–1240. 34 indexed citations
15.
Liu, Weili, Mark Stevenson, Leonard W. Seymour, & Kerry D. Fisher. (2008). Quantification of siRNA using competitive qPCR. Nucleic Acids Research. 37(1). e4–e4. 16 indexed citations
16.
Green, Nicola K., Jo Morrison, Sarah Hale, et al.. (2008). Retargeting polymer‐coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer. The Journal of Gene Medicine. 10(3). 280–289. 47 indexed citations
17.
Stevenson, Mark, Víctor Ramos, Surjeet Singh, et al.. (2008). Delivery of siRNA mediated by histidine-containing reducible polycations. Journal of Controlled Release. 130(1). 46–56. 62 indexed citations
18.
Stevenson, Mark, Ashley Hale, Mark Lyons, et al.. (2005). Chick embryo lethal orphan virus can be polymer-coated and retargeted to infect mammalian cells. Gene Therapy. 13(4). 356–368. 15 indexed citations
19.
Stevenson, Mark, et al.. (2000). DepoFoam™ technology: a vehicle for controlled delivery of protein and peptide drugs. Journal of Controlled Release. 64(1-3). 155–166. 116 indexed citations
20.
Stevenson, Mark, Susan J. Armstrong, B. V. Ford‐Lloyd, & George Jones. (1998). Comparative Analysis of Crossover Exchanges and Chiasmata in Allium Cepa × Fistulosum After Genomic In Situ Hybridization (GISH). Chromosome Research. 6(7). 567–574. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yating Tu Breakdown of academic impact, for papers by Gianluca Carlesso Breakdown of academic impact, for papers by Stephen H. Wrzesinski Breakdown of academic impact, for papers by Wentao Deng Breakdown of academic impact, for papers by Sachiko Hirosue Breakdown of academic impact, for papers by Joseph D. Ferrari Breakdown of academic impact, for papers by Jeremy B. Foote Breakdown of academic impact, for papers by Sheng Hou Breakdown of academic impact, for papers by Christian H.K. Lehmann
Rankless by CCL
2026